Back to today’s briefing

Story perspectives

AI Test Identifies Prostate Cancer Patients for Life-Saving Treatment

6/2/2025

37 5

Summary

Story summary

A groundbreaking AI test has emerged, pinpointing men with high-risk, non-metastatic prostate cancer who stand to gain from abiraterone treatment. Unveiled at the American Society of Clinical Oncology meeting, the test revealed that 25% of patients possess biomarkers for a favorable response, drastically cutting five-year mortality rates. Experts are calling on NHS England to endorse this vital treatment.

1 of 1

Story summary

A groundbreaking AI test has emerged, pinpointing men with high-risk, non-metastatic prostate cancer who stand to gain from abiraterone treatment. Unveiled at the American Society of Clinical Oncology meeting, the test revealed that 25% of patients possess biomarkers for a favorable response, drastically cutting five-year mortality rates. Experts are calling on NHS England to endorse this vital treatment.